About Us

The new gold standard in name safety testing.

SafeMark is a collaborative team of experienced branding, marketing, and regulatory professionals who bring extensive pharmaceutical knowledge as well as keen strategic insights to work with the healthcare industry on their new and existing product development projects.

SafeMark’s primary objective is to provide healthcare clients with a simple, transparent and standardized approach to name safety testing intended for regulatory review. This objective is met by offering SafeMark’s Power of 3 Methodology to evaluate the likelihood of confusion between the proposed proprietary name and existing drug product names.

At SafeMark, we are dramatically evolving the healthcare industry’s expectations toward excellence in safety testing.


SafeMark is led by President Dyan Rowe Davis, B.S. Pharm., R.Ph., J.D. Unlike many in the branding arena, Dyan’s experience and education in pharmacy and law provides clients with a review that is from both a regulatory and marketing perspective. As a pharmacist with over two decades of experience, Dyan provides clients with a practical review of each name candidate being evaluated.